Skip to content

Medical-device intelligence

LQN: Latex Agglutination Assay, Rubella

FDA product code LQN: Latex Agglutination Assay, Rubella. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LQN
FDA device name
Latex Agglutination Assay, Rubella
Device class
2
Regulation number
866.3510
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

13 clearance records and 0 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from May 20, 1985 to Jul 16, 2003.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LQN · Latex Agglutination Assay, Rubella130

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
RUBELLACOLK031490 · LQNImmunostics Inc.,510(k)Jul 16, 2003FDA decision date
COPALIS TORC TOTAL ANTIBODY ASSAYK970931 · LQNSienna Biotech, Inc.510(k)Apr 24, 1997FDA decision date
COPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY ASSAYSK961784 · LQNSienna Biotech, Inc.510(k)Oct 31, 1996FDA decision date
MUREX RUB-EXK954920 · LQNMurex Diagnostics, Inc.510(k)Aug 21, 1996FDA decision date
COLORSLIDER RUBELLAK952544 · LQNSeradyn, Inc.510(k)Jan 17, 1996FDA decision date
RUBALEX, MODIFICATIONK912391 · LQNOrion Corp.510(k)May 4, 1992FDA decision date
RESUBMITTED MODIFIED RUBALEXK901637 · LQNOrion Corp.510(k)Apr 26, 1990FDA decision date
MODIFIED RUBAGENK896433 · LQNBiokit USA, Inc.510(k)Nov 29, 1989FDA decision date
RUBAGENK893755 · LQNBiokit USA, Inc.510(k)Aug 21, 1989FDA decision date
RUBALEX (REVISED VERSION)K861881 · LQNOrion Corp.510(k)Jun 4, 1986FDA decision date
RUBALEXK852788 · LQNOrion Corp.510(k)Mar 12, 1986FDA decision date
VIROGEN RUBELLA MICROTITER TESTK844436 · LQNArmkel, LLC510(k)May 21, 1985FDA decision date
VIROGEN RUBELLA SLIDE TESTK844435 · LQNArmkel, LLC510(k)May 20, 1985FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗